SEC Form 4 · accession 0001104659-19-011639
MARINUS PHARMACEUTICALS INC · MRNS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael R Dougherty
Director
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 6:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267813
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $3.96 | Feb 26, 2019 | A | 35,000 | A | — | Feb 26, 2029 | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F15,833 options to purchase shares of common stock vest immediately on 2/26/19. The remainder vest in 10 equal monthly installments commencing 3/1/19.